As of October 8, 2026, CBD (Cannabidiol, hemp-derived) is legal to sell at retail with restrictions in California as edible / ingestible. California: ingestibles may contain only CBD/CBN isolate with no THC; 21+, 5 servings per package. Controlling source: CDPH Assembly Bill 8 FAQ.
Verified October 8, 2026 · confidence: confirmedAB 8 (Stats. 2025, ch. 248) took effect Jan. 1, 2026. Per CDPH, industrial hemp extract used in food, beverages, dietary supplements or processed pet food 'cannot contain tetrahydrocannabinol (THC) or any synthetic cannabinoids'; only CBD or CBN isolate (over 99% of tested peaks) may be added, and emergency rules keep a 21+ purchase age and a five-servings-per-package limit for final form products for human consumption. Manufacturers need a CDPH IHEO registration. Cosmetics may contain up to 0.3% total THC. Applies to CBD ingestibles (oil/tincture, capsules, gummies, drinks). Limit noted: CBD or CBN isolate only (>99%); no detectable total THC; 21+; max 5 servings per package; IHEO-registered manufacturer. Pending: 2028-01-01: AB 8 staged provisions move hemp extraction licensing to DCC and CDPH IHEO authorizations narrow to foods, beverages, supplements, pet food and cosmetics. Federal: from 2026-12-11 the federal hemp definition excludes final hemp-derived cannabinoid products (ingested, topical or animal use) with more than 0.4 mg combined total THC per container (Pub. L. 119-37 div. B sec. 781, as delayed by Pub. L. 119-103 sec. 2019); full-spectrum CBD above 0.4 mg per container becomes marijuana federally in every state.
cannot contain tetrahydrocannabinol (THC) or any synthetic cannabinoids
As of October 8, 2026, CBD (Cannabidiol, hemp-derived) is illegal to sell at retail in California as flower / raw plant. California bans sale of hemp flower and hemp pre-rolls (AB 8, eff. Jan 1, 2026); export-only manufacturing allowed. Effective 2026-01-01. Controlling source: Cal. Bus. & Prof. Code 26070.2 (Stats. 2025, Ch. 248, Sec. 17, AB 8; eff. Jan 1, 2026).
Verified October 8, 2026 · confidence: confirmedAB 8 (Stats. 2025, ch. 248) added B&P 26070.2, which provides that a person shall not sell, offer, or provide in the state any hemp flower or pre-roll containing hemp flower or hemp-derived cannabinoids, whether infused or not, and also bars inhalable products with hemp-derived THC. DCC lists hemp flower and inhalable hemp products such as pre-rolls as prohibited; CDPH says manufacturing inhalables solely for out-of-state sale is still allowed under an IHEO. The Legislative Counsel's Digest also describes a Uniform Controlled Substances Act prohibition on sale or delivery of hemp flower and prerolls for consumption in the state (operative text not fetched). This covers CBD and CBG cigarettes, pre-rolls and raw flower regardless of THC. Penalty: DCC/CDPH seizure, embargo and civil penalties plus the Health and Safety Code provision; exact amounts not fetched. Official leginfo returned 403; chaptered text read via LegiScan. Applies to CBD cigarettes, pre-rolls and flower. Flags: sale ban True, manufacture-only ban False, shipping ban True, 21+ True, license True, total-THC flower test True. Pending: 2028-01-01: DCC takes over inhalable hemp manufacturing and intoxicating hemp must be made, tested and sold in the licensed cannabis framework (AB 8 staged provisions). Federal: hemp redefinition limiting hemp-derived products to 0.4 mg total THC per container now takes effect 2026-12-11 (moved from 2026-11-12 by H.R. 6500, signed 2026-09-02, per Foley Hoag Sept 2026); a 0.3% total-THC pre-roll can exceed 0.4 mg per container. Law text: Cal. Health & Safety Code 111921.5-111921.6 from the official source (shared with the THCV row). The quoted excerpt was read on a mirror and is not inside the stored official section.
(c) Hemp flower or a pre-roll that contains hemp flower or hemp-derived cannabinoids, whether infused or not.
As of October 8, 2026, CBD (Cannabidiol, hemp-derived) is legal to sell at retail with restrictions in California as other. California: processed pet food with hemp must contain no THC (CBD/CBN isolate only). Controlling source: CDPH Assembly Bill 8 FAQ.
Verified October 8, 2026 · confidence: confirmedAB 8 (Stats. 2025, ch. 248) took effect Jan. 1, 2026. Per CDPH, industrial hemp extract used in food, beverages, dietary supplements or processed pet food 'cannot contain tetrahydrocannabinol (THC) or any synthetic cannabinoids'; only CBD or CBN isolate (over 99% of tested peaks) may be added, and emergency rules keep a 21+ purchase age and a five-servings-per-package limit for final form products for human consumption. Manufacturers need a CDPH IHEO registration. Cosmetics may contain up to 0.3% total THC. AB 1885 (2022) had allowed hemp in pet products; AB 8 now subjects processed pet food to the extract rules. Applies to CBD pet products. Limit noted: No THC; CBD/CBN isolate; IHEO registration. Pending: 2028-01-01: AB 8 staged provisions move hemp extraction licensing to DCC and CDPH IHEO authorizations narrow to foods, beverages, supplements, pet food and cosmetics. Federal: from 2026-12-11 the federal hemp definition excludes final hemp-derived cannabinoid products (ingested, topical or animal use) with more than 0.4 mg combined total THC per container (Pub. L. 119-37 div. B sec. 781, as delayed by Pub. L. 119-103 sec. 2019); full-spectrum CBD above 0.4 mg per container becomes marijuana federally in every state.
cannot contain tetrahydrocannabinol (THC) or any synthetic cannabinoids
As of October 8, 2026, CBD (Cannabidiol, hemp-derived) is legal to sell at retail with restrictions in California as topical. California: CBD cosmetics allowed up to 0.3% total THC under CDPH registration and labeling rules. Controlling source: CDPH Assembly Bill 8 FAQ.
Verified October 8, 2026 · confidence: confirmedAB 8 (Stats. 2025, ch. 248) took effect Jan. 1, 2026. Per CDPH, industrial hemp extract used in food, beverages, dietary supplements or processed pet food 'cannot contain tetrahydrocannabinol (THC) or any synthetic cannabinoids'; only CBD or CBN isolate (over 99% of tested peaks) may be added, and emergency rules keep a 21+ purchase age and a five-servings-per-package limit for final form products for human consumption. Manufacturers need a CDPH IHEO registration. Cosmetics may contain up to 0.3% total THC. Applies to CBD topicals. Limit noted: 0.3% total THC dry weight; IHEO registration; labeling and testing. Pending: 2028-01-01: AB 8 staged provisions move hemp extraction licensing to DCC and CDPH IHEO authorizations narrow to foods, beverages, supplements, pet food and cosmetics. Federal: from 2026-12-11 the federal hemp definition excludes final hemp-derived cannabinoid products (ingested, topical or animal use) with more than 0.4 mg combined total THC per container (Pub. L. 119-37 div. B sec. 781, as delayed by Pub. L. 119-103 sec. 2019); full-spectrum CBD above 0.4 mg per container becomes marijuana federally in every state.
cannot contain tetrahydrocannabinol (THC) or any synthetic cannabinoids
| Form | Status | Headline | Verified |
|---|---|---|---|
| Edible / ingestible | Restricted | California: ingestibles may contain only CBD/CBN isolate with no THC; 21+, 5 servings per package. | 2026-10-08 |
| Flower / raw plant | Illegal | California bans sale of hemp flower and hemp pre-rolls (AB 8, eff. Jan 1, 2026); export-only manufacturing allowed. | 2026-10-08 |
| Other | Restricted | California: processed pet food with hemp must contain no THC (CBD/CBN isolate only). | 2026-10-08 |
| Topical | Restricted | California: CBD cosmetics allowed up to 0.3% total THC under CDPH registration and labeling rules. | 2026-10-08 |
Among California's 3 neighbors, Nevada and Oregon are restricted; Arizona is gray area.
Map and neighbor comparison show edible / ingestible. Open the interactive map · Every compound in California
Federal gray area. FDA: CBD barred from food and supplements (enforcement discretion); 0.4 mg per container cap starts Dec 11, 2026. Federal detail
8 instruments on file for this compound's framework in California; 14 of 15 citations above are official sources. Each text carries its source and a fingerprint that changes when the law does.
3118b1968f6e7f68A person shall not sell, offer, or provide a product in the state that is any of the following: (a) An alcoholic beverage that contains cannabinoids, including, but not limited to, an infusion of cannabis or cannabinoids derived from industrial hemp into an alcoholic beverage. (b) An inhalable cannabis product containing tetrahydrocannabinols derived from industrial hemp. (c) Hemp flower or a pre-roll that contains hemp flower or hemp-derived cannabinoids, whether infused or not. (d) A product containing synthetic cannabinoids. (e) A cannabis product manufactured outside the licensed market. (Amended by Stats. 2025, Ch. 248, Sec. 17. (AB 8) Effective January 1, 2026.) Manufacture or sale of inhalable hemp products is prohibited. Manufacture of inhalable hemp products for the sole purpose of sale in other states is not prohibited. (Amended by Stats. 2025, Ch. 248, Sec. 35. (AB 8) Effective January 1, 2026.)
c7c31c6e95fee2a8Bus. & Prof. Code Sec. 26070.2 (amended by AB 8 SEC. 17): A person shall not sell, offer, or provide a product in the state that is any of the following: (a) An alcoholic beverage that contains cannabinoids, including, but not limited to, an infusion of cannabis or cannabinoids derived from industrial hemp into an alcoholic beverage. (b) An inhalable cannabis product containing tetrahydrocannabinols derived from industrial hemp. (c) Hemp flower or a pre-roll that contains hemp flower or hemp-derived cannabinoids, whether infused or not. (d) A product containing synthetic cannabinoids. (e) A cannabis product manufactured outside the licensed market. Bus. & Prof. Code Sec. 26080(c) (amended): This division does not prohibit industrial hemp or cannabis products derived exclusively from industrial hemp from either of the following: (1) Being continuously transported through California without entering the licensed market, provided they are not sold in California. (2) Being shipped out of California by a licensee. Bus. & Prof. Code Sec. 26003 (added by AB 8 SEC. 2): This division does not prohibit a licensee from manufacturing, distributing, or selling products that contain industrial hemp, as defined in Section 11018.5 of the Health and Safety Code, or cannabinoids, extracts, or derivatives from industrial hemp, if the product complies with all applicable state laws and regulations, including Division 24 (commencing with Section 81000) of the Food and Agricultural Code or Chapter 9 (commencing with Section 111920) of Part 5 of Division 104 of the Health and Safety Code, as applicable. Health & Safety Code Sec. 111920(m)-(n) (as amended by AB 8): 'CBD isolate' means a compound extracted from cannabis or industrial hemp consisting of cannabidiol, with a purity level greater than 99 percent and that does not contain any form of tetrahydrocannabinol or synthetic cannabinoid. 'CBN isolate' means a compound extracted from cannabis or industrial hemp consisting of cannabinol, with a purity level greater than 99 percent, and that does not contain any form of tetrahydrocannabinol or synthetic cannabinoid. CDPH DPH-24-005E (emergency regulation, Health & Safety Code Sec. 111921 et seq.): Industrial hemp food, food additives, beverages, and dietary supplements intended for human consumption must contain no detectable THC per serving; such products cannot be sold to a person under 21 years of age; and a package may contain no more than five servings.
d791bb80c847b6dfSection 23010. List of Intoxicating Cannabinoids. (a) In addition to delta-8 tetrahydrocannabinol (THC), delta-9 tetrahydrocannabinol (THC), delta-10 tetrahydrocannabinol (THC), and tetrahydrocannabinolic acid (THCA), the following are included in the definition of "THC" or "THC or comparable cannabinoid" and include any metabolites, derivatives, salts, isomers, and any salt or acid of an isomer of: (1) Delta-5 tetrahydrocannabinol (THC); (2) Delta-6 tetrahydrocannabinol (THC); (3) Delta-6a tetrahydrocannabinol (THC); (4) Delta-7 tetrahydrocannabinol (THC); (5) Delta-10a tetrahydrocannabinol (THC); (6) Delta-11 tetrahydrocannabinol (THC); (7) Delta-11-Hydroxy- tetrahydrocannabinol (THC); (8) Exo-tetrahydrocannabinol; (9) naphthalen-1-yl-(1-pentylindol-3-yl)methanone or commonly known as JWH-018; 1-pentyl-3-(1-naphthoyl)indole (JWH-018) (10) (1-butylindol-3-yl)-naphthalen-1-ylmethanone or commonly known as JWH-073; 1-butyl-3-(1-naphthoyl)indole (JWH-073); (11) [1-(2-morpholin-4-ylethyl)indol-3-yl]-naphthalen-1-ylmethanone or commonly known as JWH-200; 1-pentyl-3-(4-methoxynaphthoyl)indole (14-JWH-200) (12) 1-[1-(5-hydroxypentyl)indol-3-yl]-2-(2-methoxyphenyl)ethanone or commonly known as JWH-250; 1-pentyl-3-(2-methoxynaphthoyl)indole (JWH-250); (13) (4-chloronaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone or commonly known as JWH-398; 1-pentyl-3-(4-chloronaphthoyl)indole (JWH-398); (14) 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol or commonly known as CP-47,497; 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497); (15) (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol or commonly known as HU-210; (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c] chromen-1-ol (HU-210); (16) (6a,10a)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10atetrahydro-6H-benzo[c]chromen-1-ol or commonly known as HU-211; (6a,10a)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol (HU-211); (17) All tetrahydrocannabivarins (THCV), including but not limited to delta-8 tetrahydrocannabivarin and similar; (18) All metabolites of tetrahydrocannabinol (THC), including but not limited to 11-hydroxy-THC, 3-hydroxy-THC, and 7-hydroxy-THC; (19) Any combination of the compounds, including but not limited to hexahydrocannabiphorol-O-ester and this list; (20) All hydrogenated forms of tetrahydrocannabinol (THC), including but not limited to hexahydrocannabinol (HHC), hexahydrocannabiphorol (HHCP), and hexahydrocannabihexol (HHCH); (21) All hydrogenated forms of hexahydrocannabinol (HHC) including but not limited to 8-hydroxyhexahydrocannabinol, 10-hydroxyhexahydrocannabinol; (22) All ester forms of tetrahydrocannabinol (THC), including but not limited to delta-8 THC-O-acetate, delta-9 THC-O-acetate, and hexahydrocannabinol-O-acetate; (23) Analogues of tetrahydrocannabinols with alkyl chain of four or more carbon atoms, including but not limited to tetrahydrocannabiphorols (THCP), tetrahydrocannabioctyls, tetrahydrocannabihexols (THCH), tetrahydrocannabidiol (THC-JD), and tetrahydrocannabutols; (24) Tetrahydrocannabinol acetate (THC-O); (25) [1-(5-fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone or commonly known as XLR-11; N-(1-Amino-1-methyl-ethyl)-5-fluoropentyl-1-naphthalen-2-yl-1H-indole-3-carboxamide (XRL-11 &15); (26) (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone or commonly known as UR-144; N-(1-Amino-1-methyl-ethyl)-5-fluoropentyl-1-naphthalen-2-yl-1H-indole-3-carboxamide (UR-144); (27) [1-[(4-fluorophenyl)methyl]indol-3-yl]-(2,2,3,3-tetramethylcyclopropyl)methanone or commonly known as FUB-144; N-(1-Amino-1-methyl-ethyl)-5-fluoropentyl-1-naphthalen-2-yl-1H-indole-3-carboxamide (FUB-144); (28) methyl (2S)-2-[[1-[(4-fluorophenyl)methyl]indazole-3-carbonyl]amino]-3-methylbutanoate or commonly known as AMB-FUBINACA; N-(1-Amino-1-methyl-ethyl)-5-fluoropentyl-1-naphthalen-2-yl-1H-indole-3-carboxamide (AMB-FUBINACA); (29) (1-(5-fluoropentyl)-1H-indazol-3-yl)(naphthalen-1-yl)methanone or commonly known as THJ-2201; and (3-[(1R,4R)-Isopropyl-2-methyl-1,3-benzodioxol-5-yl]-N-(2,4-dimethyl-3-methylbenzoyl)-N-methyl-1,2,3,4-tetrahydroisoquinolin-6-amine) (THJ-220); and (30) (2-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone or commonly known as RCS-4. (3-[(1R,4R)-Isopropyl-2-methyl-1,3-benzodioxol-5-yl]-N-(2,4-dimethyl-3-methylbenzoyl)-N-methyl-1,2,3,4-tetrahydroisoquinolin-6-amine) (RCS-4). Note: Authority cited: Sections 100275, 110065, 111921.7, and 131200, Health and Safety Code. Reference: Sections 111920, 111921.7, 111925, 131095, and 131100, Health and Safety Code.
8771df111ec669a7Article 1. Definitions. Section 23000. Definitions. (a) For the purposes of this subchapter, the following definitions apply regarding industrial hemp: (1) "Detectable" means any amount of analyte, subject to the limit of detection. (2) "Limit of detection" means the lowest quantity of a substance or an analyte that can be reliably distinguished from the absence of that substance within a specified confidence limit. Note: Authority cited: Sections 100275, 110065, 111921.7, 111922, 111925, and 131200, Health and Safety Code. Reference: Sections 111920, 111921.7, 111925, 111926, and 131100, Health and Safety Code. Article 2. General Provisions Section 23005. Age Requirement for Human Food. A person shall not offer or sell industrial hemp final form food products intended for human consumption, including food, food additives, beverages, and dietary supplements, to a person under 21 years of age. Note: Authority cited: Sections 100275, 110065, 111921.3, and 131200, Health and Safety Code. Reference: Sections 111921, 111921.3, and 131095, Health and Safety Code. Article 3. Manufacture Section 23100. Serving and Package Requirements. (a) An industrial hemp final form food product intended for human consumption including food, food additives, beverages, and dietary supplements shall have the following: (1) Each serving in a package shall have no detectable amount of total THC, and (2) Each package shall have no more than five servings, and (3) The serving and package sizes shall be determined using the same federal standards as non-industrial hemp food products pursuant to Health and Safety Code section 111926, 110085, and 110095, unless specified in this subchapter or Part 5 of Division 104 of the Health and Safety Code. (b) An independent testing laboratory shall calculate and establish the limit of detection (LOD) for chemical method analyses according to any of the following methods: (1) Signal-to-noise ratio of between 3:1 and 2:1; (2) Standard deviation of the response and the slope of calibration curve using a minimum of 7 spiked blank samples calculated as follows; LOD = (3.3 x standard deviation of the response) / slope of the calibration curve; or (3) A method published by the United States Food and Drug Administration (USFDA) or the United States Environmental Protection Agency (USEPA). (c) A manufacturer of industrial hemp final form food product shall provide documentation that includes a certificate of analysis from an independent testing laboratory to confirm the amount of total THC in the final form food product does not exceed the total THC per serving size limits as set forth in this subchapter. (d) A person shall not manufacture, warehouse, distribute, offer, advertise, market, or sell industrial hemp final form food products intended for human consumption including food, food additives, beverages, and dietary supplements that are above the limit of detection for total THC per serving. Note: Authority cited: Sections 100275, 110065, 111922, 111925, and 131200, Health and Safety Code. Reference: Sections 110085, 110095, 110100, 111920, 111921, 111922, 111925, 111925.2, 111926, 111926.2, 131095, and 131100, Health and Safety Code; and Part 101, Title 21 Code of Federal Regulations.
40cb4f716cffa23c111921.5. (a) Unless explicitly approved by the federal Food and Drug Administration, industrial hemp shall not be included in products in any of the following categories: (1) Medical devices. (2) Prescription drugs. (3) A product containing nicotine or tobacco. (4) An alcoholic beverage. (b) The department may prohibit the inclusion of industrial hemp in other products when it poses a risk to human or animal health through regulation. (c) Cannabis and cannabis products are not subject to this section. 111921.6. (a) Manufacture or sale of inhalable products is prohibited. Manufacture of inhalable products for the sole purpose of sale in other states is not prohibited. (b) This section shall become inoperative and is repealed on the effective date of a measure passed by the Legislature that establishes a tax on inhalable products and states the intent of the Legislature to fulfill the requirements of this section.
bf10afa940b8886a11018.5. (a) (1) "Industrial hemp" or "hemp" means types of the plant Cannabis sativa Linnaeus or any part of that plant with a total tetrahydrocannabinol concentration of no more than 0.3 percent on a dry weight basis and is limited to only agricultural products, including seeds, propagated plant material, immature or mature plants, harvested plants, mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, or any preparation that does not contain cannabinoids. (2) Total tetrahydrocannabinol concentration includes both delta-9 tetrahydrocannabinol and tetrahydrocannabinolic acid, and shall be calculated using the following equation: Total THC concentration (mg/g) +/- the measurement of uncertainty, as defined by the Department of Food and Agriculture. (b) Industrial hemp shall not be subject to the provisions of this division or of Division 10 (commencing with Section 26000) of the Business and Professions Code, except upon entry into the California licensed market under that division, and shall be regulated by the Department of Food and Agriculture in accordance with the provisions of Division 24 (commencing with Section 81000) of the Food and Agricultural Code, inclusive. (c) The sale or delivery of hemp flower and hemp prerolls within the state is prohibited.
69d75eb0dd8b0500111920. For purposes of this chapter, the following definitions apply: (a) "Department" means the State Department of Public Health. (b) "Established and approved industrial hemp program" means a program that meets any applicable requirements set forth in federal law regarding the lawful and safe cultivation of industrial hemp. (c) "Final form product" is a product intended for consumer use to be sold at a retail premise. (d) "Hemp manufacturer" means either of the following: (1) A processor extracting cannabinoids from hemp biomass. (2) A processor purchasing industrial hemp raw extract for the purpose of manufacturing a final form product. (e) "Independent testing laboratory" means a laboratory that meets all of the following requirements: (1) Does not have a direct or indirect interest in the entity for which testing is being done. (2) Does not have a direct or indirect interest in a facility that cultivates, processes, distributes, dispenses, or sells raw hemp products in this state or in another jurisdiction. (3) Does not have a license issued pursuant to Division 10 (commencing with Section 26000) of the Business and Professions Code, other than as a licensed testing laboratory. (4) Is either of the following: (A) A testing laboratory licensed pursuant to Division 10 (commencing with Section 26000) of the Business and Professions Code, if the licensed testing lab has notified the Department of Cannabis Control. (B) Accredited by a third-party accrediting body as a competent testing laboratory pursuant to ISO/IEC 17025 of the International Organization for Standardization. (f) "Industrial hemp" has the same meaning as in Section 11018.5. "Industrial hemp" does not include cannabinoids produced through chemical synthesis. (g) (1) "Industrial hemp product" or "hemp product" means a finished product containing industrial hemp that meets all of the following conditions: (A) Is a cosmetic, food, food additive, dietary supplement, or herb. (B) (i) Is for human or animal consumption. (ii) "Animal" does not include livestock or a food animal as defined in Section 4825.1 of the Business and Professions Code. (iii) Does not include THC isolate as an ingredient. (2) "Industrial hemp product" does not include industrial hemp or a hemp product that has been approved by the United States Food and Drug Administration or a hemp product that includes industrial hemp or hemp that has received Generally Recognized As Safe (GRAS) designation. For purposes of nonfood applications, "industrial hemp product" does not include a hemp product that contains derivatives, substances, or compounds derived from the seed of industrial hemp. (h) (1) "Manufacture" or "manufacturing" means to compound, blend, extract, infuse, or otherwise make or prepare an industrial hemp product. (2) "Manufacturing" includes all aspects of the extraction process, infusion process, and packaging and labeling processes, including processing, preparing, holding, and storing of industrial hemp products. (3) "Manufacturing" also includes processing, preparing, holding, or storing hemp components and ingredients. (4) "Manufacturing" does not include planting, growing, harvesting, drying, curing, grading, or trimming a plant or part of a plant. (i) "Raw extract" or "industrial hemp raw extract" means extract not intended for consumer use and that contains a THC concentration of not more than an amount determined by the department in regulation. (j) "Raw hemp product" means a product that is derived from industrial hemp that is intended to be included in a food, beverage, dietary supplement, or cosmetic. (k) "Retail" has the same meaning as in Section 113895. (l) "THC" or "THC or comparable cannabinoid" means any of the following: (1) Tetrahydrocannabinolic acid. (2) Any tetrahydrocannabinol, including, but not limited to, Delta-8-tetrahydrocannabinol, Delta-9-tetrahydrocannabinol, and Delta-10-tetrahydrocannabinol, however derived, except that the department may exclude one or more isomers of tetrahydrocannabinol from this definition under subdivision (a) of Section 111921.7. (3) Any other cannabinoid, except cannabidiol, that the department determines, under subdivision (b) of Section 111921.7, to cause intoxication. (m) "THCA" means tetrahydrocannabinolic acid, CAS number 23978-85-0. (n) "Total THC" means the sum of THC and THCA. Total THC shall be calculated using the following equation: total THC concentration (mg/g) +/- the measurement of uncertainty, as defined by the United States Department of Agriculture.
40cb4f716cffa23c111921.5. (a) Unless explicitly approved by the federal Food and Drug Administration, industrial hemp shall not be included in products in any of the following categories: (1) Medical devices. (2) Prescription drugs. (3) A product containing nicotine or tobacco. (4) An alcoholic beverage. (b) The department may prohibit the inclusion of industrial hemp in other products when it poses a risk to human or animal health through regulation. (c) Cannabis and cannabis products are not subject to this section. 111921.6. (a) Manufacture or sale of inhalable products is prohibited. Manufacture of inhalable products for the sole purpose of sale in other states is not prohibited. (b) This section shall become inoperative and is repealed on the effective date of a measure passed by the Legislature that establishes a tax on inhalable products and states the intent of the Legislature to fulfill the requirements of this section.
Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.
About · Methodology · Glossary · Changes · Data & API · llms.txt · Sitemap